In a logistic regression model that included these eight markers jointly (adjusted for age, sex, and current use of NSAIDs), only GRO remained statistically significantly inversely associated with dysplasia with an OR (95% CI) of 0.64 (0.45–0.91), although BCA‐1 showed a borderline association with dysplasia (OR: 0.74, 95%CI: 0.54–1.01; Table S4). Here, CXCL13 is linked to dysplasia.